• FILE - This Aug. 31, 2015, file photo, shows the Monsanto logo on display at the Farm Progress Show in Decatur, Ill.  German pharmaceutical giant Bayer AG says it's increasing its bid for American seed company Monsanto Co. The Leverkusen-based drug and chemicals company said in a statement early Tuesday  Sept. 6, 2016 it was offering US $127.50 per Monsanto share, up from the previous US $125 a share offer. Excluding debt of about US $9 billion, that values Monsanto at US $55.8 billion, about  US $1 billion more than the previous offer. (AP Photo/Seth Perlman, File)

    FILE - This Aug. 31, 2015, file photo, shows the Monsanto logo on display at the Farm Progress Show in Decatur, Ill. German pharmaceutical giant Bayer AG says it's increasing its bid for American seed company Monsanto Co. The Leverkusen-based drug ... and chemicals company said in a statement early Tuesday Sept. 6, 2016 it was offering US $127.50 per Monsanto share, up from the previous US $125 a share offer. Excluding debt of about US $9 billion, that values Monsanto at US $55.8 billion, about US $1 billion more than the previous offer. (AP Photo/Seth Perlman, File) (The Associated Press)

  • FILE - In this May 23, 2016 file picture the Bayer AG corporate logo is displayed on a building of the German drug and chemicals company in Berlin, Germany. German pharmaceutical giant Bayer AG says it's increasing its bid for American seed company Monsanto Co. The Leverkusen-based drug and chemicals company said in a statement early Tuesday  Sept. 6, 2016 it was offering US $127.50 per Monsanto share, up from the previous US $125 a share offer. Excluding debt of about US $9 billion, that values Monsanto at US $55.8 billion, about  US $1 billion more than the previous offer. (AP Photo/Markus Schreiber)

    FILE - In this May 23, 2016 file picture the Bayer AG corporate logo is displayed on a building of the German drug and chemicals company in Berlin, Germany. German pharmaceutical giant Bayer AG says it's increasing its bid for American seed company ... Monsanto Co. The Leverkusen-based drug and chemicals company said in a statement early Tuesday Sept. 6, 2016 it was offering US $127.50 per Monsanto share, up from the previous US $125 a share offer. Excluding debt of about US $9 billion, that values Monsanto at US $55.8 billion, about US $1 billion more than the previous offer. (AP Photo/Markus Schreiber) (The Associated Press)

Germany's Bayer raises offer for Monsanto again

Markets Associated Press

German pharmaceutical giant Bayer AG says it's increasing its bid for American seed company Monsanto Co.

Continue Reading Below

The Leverkusen-based drug and chemicals company said in a statement early Tuesday it was offering $127.50 per Monsanto share, up from the previous $125 a share offer that had valued Monsanto at around $65 billion.

It gave no further details on the takeover bid and said "there can be no assurance that the parties will enter into an agreement."

Monsanto has already rejected two offers from Bayer and described the previous offer in July inadequate.

At the time, the St. Louis company said it remained open to talks with Bayer and others about a deal.

Monsanto confirmed the new Bayer bid but would not comment further as it evaluates it.